Skip to content

ASP Isotopes Inc.: 10-Q filed 2022-12-22

What ASP Isotopes Inc. reported in its quarterly report filed 2022-12-22 (fiscal Q3 2022): 37 published measures, 92 facts as tagged in accession 0001213900-22-082183.

This filing

Form
10-Q (quarterly report)
Filed
2022-12-22
Fiscal period
fiscal Q3 2022
Accession
0001213900-22-082183 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ASP Isotopes Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-309,481,238USD
At 2021-12-317,142,638USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-303,163,019USD
At 2021-12-311,144,974USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-306,318,219USD
At 2022-06-307,408,538USD
At 2022-03-317,021,808USD
At 2021-12-315,997,664USD
At 2021-09-302,055,677USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-1,956,230USD92
2022-01-01 to 2022-09-30-3,640,988USD273
2022-04-01 to 2022-06-30-827,170USD91
2022-01-01 to 2022-03-31-857,588USD90
2021-09-13 to 2021-09-30-508,247USD18

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-2,077,859USD273
2021-09-13 to 2021-09-30-32,310USD18

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-09-303,570,632USD273
2022-07-01 to 2022-07-31354,000USD31
2021-09-13 to 2021-09-30195,712USD18
2022-07-01 to 2022-07-316,000,000ZAR31

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-09-302,850,549USD273
2021-09-13 to 2021-09-302,121,900USD18

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-3,570,632USD273
2021-09-13 to 2021-09-30-195,712USD18

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-30-6,248,915USD
At 2021-12-31-2,607,927USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-07-01 to 2022-09-3030,107,127shares92
2022-01-01 to 2022-09-3028,642,533shares273
2021-09-13 to 2021-09-302,844,444shares18

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-07-01 to 2022-09-3030,107,127shares92
2022-01-01 to 2022-09-3028,642,533shares273
2021-09-13 to 2021-09-302,844,444shares18

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.06USD/shares92
2022-01-01 to 2022-09-30-0.13USD/shares273
2021-09-13 to 2021-09-30-0.18USD/shares18

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.06USD/shares92
2022-01-01 to 2022-09-30-0.13USD/shares273
2021-09-13 to 2021-09-30-0.18USD/shares18

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-09-306,891,721USD
At 2021-12-312,988,210USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-09-30946,958USD273
2021-09-13 to 2021-09-30500,000USD18

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-1,953,780USD92
2022-01-01 to 2022-09-30-3,639,992USD273
2021-09-13 to 2021-09-30-508,247USD18

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-09-301,584,112USD
At 2021-12-313,221,283USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-302,452,198USD
At 2021-12-31303,351USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-09-301,156,253USD
At 2021-12-3159,679USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-07-01 to 2022-09-301,953,780USD92
2022-01-01 to 2022-09-303,639,992USD273
2021-09-13 to 2021-09-30508,247USD18

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-07-01 to 2022-09-30745,461USD92
2022-01-01 to 2022-09-301,191,901USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-09-3030,107,127shares
At 2021-12-3120,652,500shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-09-30431,565USD
At 2021-12-312,953,721USD
At 2021-09-301,882,801USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-09-3011,971,568USD
At 2021-12-318,380,343USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2022-09-30294,495USD
At 2021-12-3118,723USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-09-30873,997USD
At 2021-12-31933,145USD
At 2021-10-31952,521USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2022-09-30751,488USD
At 2021-10-31952,521USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2022-09-30131,408USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-09-30977,539USD
At 2021-12-3142,500USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-09-30605,174USD
At 2021-12-31267,562USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2022-07-01 to 2022-09-301,956,230USD92
2022-01-01 to 2022-09-303,640,988USD273
2021-09-13 to 2021-09-30508,247USD18

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-1,805,729USD92
2022-01-01 to 2022-09-30-3,365,216USD273
2021-09-13 to 2021-09-30-519,323USD18

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-301,208,319USD92
2022-01-01 to 2022-09-302,448,091USD273
2021-09-13 to 2021-09-30508,247USD18

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-2,450USD92
2022-01-01 to 2022-09-30-996USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-01-01 to 2022-09-303,119,560USD273
2021-09-13 to 2021-09-302,075,000USD18

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2022-07-01 to 2022-09-3020,585USD92
2022-01-01 to 2022-09-3071,343USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30763,695USD273
2021-09-13 to 2021-09-30-24,063USD18

Inspect the source

Entity
ASP Isotopes Inc. / CIK 0001921865
Captured
2026-09-21T17:41:08.651Z
SEC response SHA-256
7d5d4e3d9e273021345f6ecc534f82edc7c42da211c9e938b537490e8c6e4615

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001921865.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))